Search results for: France
Filter search results
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…Considered in Healthcare Decision-making? An overview from other countries from Office of Health Economics There were three further presentations at the conference given by: Professor Francesco Saverio Mennini, President of…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
…France, Germany, Italy, Spain and the UK. The “debate” around IBP centres on i) who benefits and who loses? and ii) how and whether it can be implemented in…
The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years
11 January 1994
…reports dealt with France, the former West Germany and the United Kingdom respectively (Andersson et al, 1992; Andersson etal, 1993; Oleksy etal, 1994). The US study was commissioned by the…
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…(HTA) agency determines how these challenges are currently addressed. This report provides an analysis of HTA agency assessments and reimbursement decisions for entrectinib and larotrectinib across England, Germany, France, Canada,…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…this debate, and of how IBP has been implemented – in its various forms – to date in the U.S., France, Germany, Italy, Spain and the UK. IBP increases the…
Are Recommendations for HTA of Gene Therapies Being Achieved?
11 September 2023
…develop country scorecards exploring the extent to which these recommendations are being achieved in eleven countries. The countries considered were: Australia, Canada, Denmark, England, France, Germany, Italy, the Netherlands, Spain,…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…at the delivery of vaccine programmes in countries that represent a range of healthcare systems, demographics, and vaccine schedules – Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand,…
Pharmaceuticals in seven nations
1 May 1985
…pharmaceutical industry, with particular reference to its structure and activities in seven countries – the Federal Republic of Germany, France, Italy, Japan, Switzerland, the United Kingdom and the United States….
The Life Cycle of Pharmaceuticals: A Cross-National Perspective
1 April 2002
…contribution to the methodology of cross-national comparisons for medicines. In this study we use comprehensive data on outpatient sales for all drugs in seven countries (Canada, France, Germany, Italy, Japan,…